[ascct] Re: ASCCT Board Member elections
- From: Kristie Sullivan <KSullivan@xxxxxxxx>
- To: "ascct@xxxxxxxxxxxxx" <ascct@xxxxxxxxxxxxx>
- Date: Tue, 9 Oct 2012 22:35:01 -0400
Correction:
The online meeting will be Nov. 2 and 1:00 pm Eastern Time.
Kristie Sullivan, MPH
Secretary
American Society for Cellular and Computational Toxicology
www.ascctox.org<http://www.ascctox.org>
On Oct 9, 2012, at 7:27 PM, Kristie Sullivan wrote:
Response requested by Oct. 26
Dear ASCCT members:
I am pleased to send you the nominations for new members of the Board of
Directors. In-person voting was held at the ASCCT annual meeting in Bethesda
September 21. In order to give members who could not attend the meeting a
chance to participate, we are offering an online survey.
PLEASE DO NOT VOTE HERE IF YOU HAVE ALREADY VOTED IN PERSON.
The survey can be accessed here: http://www.surveymonkey.com/s/LX2JJZN.
There are seven seats on the Board, including 3 Officers. Voting for an
officer's position (a "yes" vote) means that you accept their position on the
Board as well. The Board members who propose to retain their seats include:
Rodger Current, IIVS (President)
Erin Hill, IIVS (Treasurer)
Kristie Sullivan, PCRM (Secretary)
Thomas Hartung, Johns Hopkins University
Three people submitted self-nominations for the Board before the annual meeting:
Marilyn Aardema, Marilyn Aardema Consulting, LLC
John "Jack" R. Fowle III, consultant, retired US EPA
Mariana Gaça, British American Tobacco
One person was a write-in candidate at the annual meeting:
George deGeorge, MB Research
[All affiliations provided for identification purposes only.]
Short statements of experience and intent for each candidate are provided below.
We would like to propose to re-hold the Business meeting in an online meeting
format, to allow members who did not travel to the annual meeting a chance to
learn about the Society's efforts, activities, and status. The results of the
election will be announced at this meeting and by email afterwards.
We propose to hold this business meeting Nov. 2 at 2:00 pm Eastern Time. A link
to the event will be sent out shortly.
Please respond to this email with any questions, and read further for candidate
profiles:
Marilyn Aardema
Marilyn’s experience is consistent with ASCCT’s mission of developing
approaches to improve toxicology testing while addressing the 3Rs and makes her
well suited for helping ASCCT accomplish its goals. Marilyn is a globally
recognized expert and leader in the field of genetic toxicology and alternative
test development/validation. She has extensive experience as a leader and
participant of influential multi-disciplinary teams and global
scientific/policy expert groups towards scientific acceptance of new methods
with a focus on in vitro alternatives. Recently, she was on the ECVAM
Validation Management Team for cell transformation assays that have now
progressed into OECD guideline development, she has led/participated in
numerous IWGT (International Working Group on Genotoxicity Testing) groups to
harmonize assays, testing strategies, guidelines; co-leader of previous
ILSI-HESI Genotoxicity Toxicogenomics project; current member of ILSI-HESI
Genotoxicity Steering Team; previous lead of COLIPA (now CosEU) cosmetic
association project on development/validation of 3D skin genotoxicity assays;
US OECD expert; participant in past ICH guideline development for
pharmaceutical testing; member of past ECETOC task forces.
John “Jack” R. Fowle III
I’m committed to using my experience to advance ASCCT’s goal to promote
toxicology testing and research reducing and replacing animals. I led the June
2011 SAP review of the Pesticide Program’s Toxicity Testing in the 21st Century
plans. I co-chaired OECD’s VMG-NA developing internationally accepted
non-animal methods for EDCs, and was EPA’s ICCVAM representative. I directed
EPA’s Neurotoxicology Division, implementing programs to develop alternatives
to animals, and managed the research program to support the use of QSAR and
alternative animal tests. I was also Deputy Director of EPA’s Science Advisory
Board, and Science Advisor to Senator Daniel Patrick Moynihan.
Marianna Gaça
I am enthusiastic in advancing ASCCT’s goals promoting toxicology testing and
research applying the 3Rs tenet. At British American Tobacco’s R&D Centre, I
implemented and led various research programs developing in vitro models of
tobacco-related diseases and exposure systems to help determine the
toxicological and biological effects of cigarette smoke and for incorporation
into a framework to evaluate product risk. I am now leading the establishment
of international collaborations and partnerships with multi-disciplinary
organisations to help strengthen the critical science base required for tobacco
regulatory decision-making (as recently defined by the US FDA). I have been an
Executive Board member for the In Vitro Testing Industrial Platform (IVTIP)
since 2008.
George DeGeorge
I am excited to have the opportunity to serve the ASCCT in advancing the 3R’s
both in philosophy and in action. My over 20 years experience is directly
aligned with the goals of the society, having served as President of the In
Vitro and Alternatives specialty section (IVAM-SS) of the national SOT, as well
as being a member of IVTIP. In the American College of Toxicology, I was
Chairman for a Symposium entitled “In Vitro Toxicology Testing” and while on
the Education Committee I also chaired a Continuing Education Course on “In
Vitro and Alternative Toxicology Testing Methods”. My other relevant
activities have included EPA Advisory posts: Expert Panel Member –“Ensuring
Quality for In Vitro Tests” and –“The Up and Down Procedure for Acute Oral
Toxicity” which helped finalize EPA Guidelines on this test. And most
recently, Expert Panel Member –“Scientific Applicability for Use of an
Alternative Test Guideline for Dermal Sensitivity” which led to the final
framing of the EPA Guidelines for the LLNA. I was also appointed as a Member
of the Scientific Advisory Committee on Alternative Toxicology Methods (SACATM
to ICCVAM). As Director of In Vitro Toxicology at MBRL I remain very active in
the 3R’s field and our group has received 11 NIH SBIR research awards for the
development of innovative In Vitro and Alternative tests. I also serve as an
Editor on the International Board for the journal ‘Toxicology In Vitro’. I
would like to use my experience and scientific network to help both grow ASCCT
membership and expand its activities.
Kristie Sullivan, MPH
Secretary
American Society for Cellular and Computational Toxicology
www.ascctox.org<http://www.ascctox.org/>
Other related posts:
